STERIS plc STE
208.93
0.16
0.08%
as of 25 Sep
- Market cap
- $20.4B
- P/E
- 25.4×
Follow STE
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
STERIS plc (STE) Net margin
STERIS plc's net margin over the twelve months to 30 June 2026 was 13.3%, up 0.2 percentage points from fiscal 2026 (13.2%). Over the past ten years it has ranged from 2.36% (fiscal 2023) to 13.5% (fiscal 2020); the current reading is higher than 92% of that period. That is above the Medical Devices industry median of −20.4% and above the Healthcare sector median of 0.00%.
Net margin, annual
Annual
| Period | Net margin | Change (points) |
|---|---|---|
| FY2026 | 13.2% | 1.92 |
| FY2025 | 11.3% | 3.90 |
| FY2024 | 7.36% | 5.00 |
| FY2023 | 2.36% | (3.41) |
| FY2022 | 5.77% | (7.02) |
| FY2021 | 12.8% | (0.66) |
| FY2020 | 13.5% | 2.53 |
| FY2019 | 10.9% | (0.18) |
| FY2018 | 11.1% | 6.89 |
| FY2017 | 4.21% | (0.74) |
Quarterly
| Period | Net margin | Change (points) |
|---|---|---|
| Jun 2026 | 13.4% | (0.45) |
| Mar 2026 | 13.9% | 0.97 |
| Dec 2025 | 12.9% | (0.25) |
| Sep 2025 | 13.1% | 0.39 |
| 42 more quarters | Free account |
Against its own ten years
Low 2.36%
High 13.5%
Ten-year median
9.14%
Current reading's percentile
92
Net margin against peers
| Company | Net margin |
|---|---|
| DXCM DexCom, Inc. compare | 20.1% |
| STE STERIS plc | 13.3% |
| PEN Penumbra, Inc. compare | 10.7% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 9.48% |
| GEHC GE HealthCare Technologies Inc. compare | 9.33% |
| BIO Bio-Rad Laboratories, Inc. compare | 8.59% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 8.59% |
| SNN Smith & Nephew SNATS, Inc. compare | 6.71% |
| PHG Koninklijke Philips N.V. compare | 6.24% |
| Medical Devices industry median | −20.4% |
| Healthcare sector median | 0.00% |
| Market median | 0.55% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on STE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement